These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20561816)

  • 1. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.
    Revello MG; Genini E; Gorini G; Klersy C; Piralla A; Gerna G
    J Clin Virol; 2010 Aug; 48(4):255-9. PubMed ID: 20561816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of commercial rubella immunoglobulin G avidity assays.
    Mubareka S; Richards H; Gray M; Tipples GA
    J Clin Microbiol; 2007 Jan; 45(1):231-3. PubMed ID: 17093027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
    Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
    Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.
    Furione M; Rognoni V; Sarasini A; Zavattoni M; Lilleri D; Gerna G; Revello MG
    J Med Virol; 2013 Nov; 85(11):1960-7. PubMed ID: 23893782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
    Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
    J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
    Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
    J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.
    Zelini P; Fornara C; Furione M; Sarasini A; Klemens J; Arossa A; Spinillo A; Gerna G; Lilleri D
    J Clin Virol; 2019 Nov; 120():38-43. PubMed ID: 31546089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive predictive value of anti-HCMV IgM as an index of primary infection.
    De Paschale M; Agrappi C; Manco MT; Clerici P
    J Virol Methods; 2010 Sep; 168(1-2):121-5. PubMed ID: 20470827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of IgG avidity index and IgM levels for the differential diagnosis of primary from recurrent cytomegalovirus infections.
    Chakravarti A; Kashyap B; Wadhwa A
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):197-201. PubMed ID: 18094442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection.
    de Souza S; Bonon SH; Costa SC; Rossi CL
    Rev Inst Med Trop Sao Paulo; 2003; 45(6):323-6. PubMed ID: 14762632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women.
    Macé M; Sissoeff L; Rudent A; Grangeot-Keros L
    Prenat Diagn; 2004 Nov; 24(11):861-3. PubMed ID: 15565653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
    Carlier P; Harika N; Bailly R; Vranken G
    J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of the toxoplasma IgG avidity test in the serological surveillance of pregnant women].
    Soula F; Fréalle E; Durand-Joly I; Dutoit E; Rouland V; Renard E; Houfflin-Debarge V; Subtil D; Camus D; Dei-Cas E; Delhaes L
    Ann Biol Clin (Paris); 2007; 65(3):257-64. PubMed ID: 17502297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum.
    Ruellan-Eugene G; Barjot P; Campet M; Vabret A; Herlicoviez M; Muller G; Levy G; Guillois B; Freymuth F
    J Med Virol; 1996 Sep; 50(1):9-15. PubMed ID: 8890034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus.
    Revello MG; Gorini G; Gerna G
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):801-5. PubMed ID: 15242963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
    Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
    Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.